Integra LifeSciences Entering Neurosurgery Market Via NeuroCare Buy
This article was originally published in The Gray Sheet
Executive Summary
Integra LifeSciences' $25 mil. acquisition of the NeuroCare group of companies, finalized March 29, positions the firm for a strong entry into the neurosurgery market.